Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionCrossmark Global Holdings, Inc.
Latest Disclosed Ownership39,260 shares
Latest Disclosed Value $ 13,813,631
Crossmark Global Holdings, Inc. reports 17.72% decrease in ownership of AMGN / Amgen Inc.

On May 11, 2026 - Crossmark Global Holdings, Inc. filed a 13F-HR form disclosing ownership of 39,260 shares of Amgen Inc. (MX:AMGN) valued at $13,813,631 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 47,716 shares of Amgen Inc.. This represents a change in shares of -17.72% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F AMGEN COM 031162100 39,260 -8,456 -17.72 13,814 -11.55 0.2040
2026-02-03 2025-12-31 13F AMGEN COM 031162100 47,716 4,922 11.50 15,618 29.32 0.2228
2025-11-12 2025-09-30 13F AMGEN COM 031162100 42,794 1,178 2.83 12,076 3.93 0.1809
2025-08-08 2025-06-30 13F AMGEN COM 031162100 41,616 -39,273 -48.55 11,619 -53.89 0.1876
2025-04-30 2025-03-31 13F AMGEN COM 031162100 80,889 4,282 5.59 25,201 132,531.58 0.4445
2025-01-16 2024-12-31 13F AMGEN COM 031162100 76,607 1,966 2.63 20 -20.83 0.3640
2024-11-04 2024-09-30 13F AMGEN COM 031162100 74,641 -517 -0.69 24 4.35 0.4289
2024-07-29 2024-06-30 13F AMGEN COM 031162100 75,158 -18,377 -19.65 23 -11.54 0.4489
2024-05-13 2024-03-31 13F AMGEN COM 031162100 93,535 -19,880 -17.53 27 -18.75 0.5098
2024-02-13 2023-12-31 13F AMGEN COM 031162100 113,415 487 0.43 33 6.67 0.6778
2023-11-08 2023-09-30 13F AMGEN COM 031162100 112,928 46,426 69.81 31 100.00 0.6944
2023-07-31 2023-06-30 13F AMGEN COM 031162100 66,502 -2,807 -4.05 16 -6.25 0.3382
2023-05-12 2023-03-31 13F AMGEN COM 031162100 69,309 1,621 2.39 17 -5.88 0.3943
2023-01-19 2022-12-31 13F AMGEN COM 031162100 67,688 3,318 5.15 18 -99.88 0.4431
2022-11-01 2022-09-30 13F AMGEN COM 031162100 64,370 8,621 15.46 14,509 6.97 0.4026
2022-07-29 2022-06-30 13F AMGEN COM 031162100 55,749 -43,279 -43.70 13,564 -43.36 0.3515
2022-05-11 2022-03-31 13F AMGEN COM 031162100 99,028 -649 -0.65 23,947 6.79 0.5340
2022-01-10 2021-12-31 13F AMGEN COM 031162100 99,677 -3,013 -2.93 22,424 2.69 0.4870
2021-10-21 2021-09-30 13F/A-1 AMGEN COM 031162100 102,690 1,026 1.01 21,837 -11.88 0.5116
2021-10-13 2021-09-30 13F AMGEN COM 031162100 31,037 -70,627 2,616 0.2994
2021-07-21 2021-06-30 13F AMGEN COM 031162100 101,664 205 0.20 24,780 -1.83 0.5827
2021-04-15 2021-03-31 13F AMGEN COM 031162100 101,459 -3,360 -3.21 25,243 4.74 0.6252
2021-01-14 2020-12-31 13F AMGEN COM 031162100 104,819 48,907 87.47 24,100 69.59 0.6094
2020-10-08 2020-09-30 13F AMGEN COM 031162100 55,912 303 0.54 14,211 8.35 0.3985
2020-08-14 2020-06-30 13F AMGEN COM 031162100 55,609 3,130 5.96 13,116 23.28 0.3825
2020-04-28 2020-03-31 13F AMGEN COM 031162100 52,479 1,043 2.03 10,639 -14.20 0.3807
2020-02-06 2019-12-31 13F AMGEN COM 031162100 51,436 -3,888 -7.03 12,400 15.82 0.3406
2019-10-09 2019-09-30 13F AMGEN COM 031162100 55,324 -6,353 -10.30 10,706 -5.81 0.3125
2019-07-09 2019-06-30 13F AMGEN COM 031162100 61,677 -1,780 -2.81 11,366 -5.72 0.3187
2019-05-02 2019-03-31 13F AMGEN COM 031162100 63,457 -1,654 -2.54 12,056 -4.88 0.3423
2019-01-31 2018-12-31 13F AMGEN COM 031162100 65,111 -4,815 -6.89 12,675 -12.56 0.3929
2018-11-08 2018-09-30 13F/A-1 AMGEN COM 031162100 69,926 -5,346 -7.10 14,495 4.32 0.3679
2018-11-06 2018-09-30 13F AMGEN COM 031162100 75,272 0 13,895
2018-07-31 2018-06-30 13F AMGEN COM 031162100 75,272 -48,315 -39.09 13,895 -34.05 0.3727
2018-04-16 2018-03-31 13F AMGEN COM 031162100 123,587 -9,084 -6.85 21,069 -8.68 0.5446
2018-02-05 2017-12-31 13F AMGEN COM 031162100 132,671 5,331 4.19 23,071 -2.83 0.5544
2017-10-27 2017-09-30 13F AMGEN COM 031162100 127,340 0 0.00 23,743 0.00 0.6120
2017-10-25 2016-09-30 13F AMGEN COM 031162100 127,340 127,340 23,743 0.6120
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.